Last reviewed · How we verify
NCT07224867
The Effects of Liquid IV's Multi-Ingredient Recovery Supplement on Muscle Recovery Following Exercise
NA trial testing proprietary post workout recovery supplement in Muscle Damage in 30 participants. Not yet recruiting.
1 October 2026
Quick facts
| Lead sponsor | Applied Science & Performance Institute |
|---|---|
| Phase | NA |
| Status | Not yet recruiting |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | double |
| Primary purpose | treatment |
| Enrollment | 30 |
| Start date | 1 May 2026 |
| Primary completion | 1 October 2026 |
| Estimated completion | 1 October 2026 |
| Sites | 1 location across United States |
Drugs / interventions tested
- proprietary post workout recovery supplement
- Control placebo
Conditions studied
- Muscle Damage — all drugs for Muscle Damage →
- Strength Recovery — all drugs for Strength Recovery →
- Perceived Recovery — all drugs for Perceived Recovery →
- Perceived Muscle Soreness — all drugs for Perceived Muscle Soreness →
Sponsor
Applied Science & Performance Institute — full company profile →
Who can join
Adults 18 to 55, any sex, with Muscle Damage or Strength Recovery. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this study is to evaluate the efficacy of a multi-ingredient recovery supplement . The research will focus on strength recovery and performance maintenance assessing reductions in soreness and inflammation, as well as muscle repair and damage mitigation. By investigating these key recovery metrics, this study aims to investigate the efficacy of this supplement as a solution for active individuals seeking to optimize post-exercise recovery.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07224867
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Muscle Damage
Currently open trials in the same condition.
- NCT06837298 — The Effect of Vicia Faba Hydrolysate Supplementation on Muscle Strength Recovery · NA · recruiting
- NCT06432868 — Solarplast (R) Supplementation Effects Following High-intensity Resistance Exercise · NA · recruiting
- NCT06992271 — Comparing Two Eccentric Protocols on Muscle Damage · NA · recruiting
- NCT04900506 — Surgical Approach in Hemiarthroplasty. A Randomized Clinical Trial Comparing Posterior and Anterior Approach · NA · active not recruiting
- NCT04549610 — HMB and Exercise-induced Muscle Damage · Phase 2, PHASE3 · recruiting
Other Applied Science & Performance Institute trials
Trials by the same sponsor.
- NCT07495592 — The Acute Effects of Onnit Alpha Brain on Cognition and Mood States · NA · not yet recruiting
- NCT07225608 — The Acute Effects of Liquid IV's Pre-Workout Supplement on Muscle Endurance & Strength, Energy, and Cognition · NA · completed
- NCT06959472 — Impact of Hyperarch Fascia Training on Ankle Health and Exercise Performance · NA · completed
- NCT06883292 — The Effects of Tyrosol and Creatine on Endurance, Strength, and Fatigue Resistance in Healthy Adults · NA · completed
- NCT06583941 — Effects of Indena's Virtiva® Plus Ginkgo Biloba Extract on Stress, and Cognitive Performance · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07224867 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Applied Science & Performance Institute
- Last refreshed: 9 April 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07224867.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing